tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Avalo Therapeutics Inc

AVTX
Add to Watchlist
17.770USD
-0.380-2.09%
Close 07-23 16:00（ET）Quotes delayed by 15 min
437.81MMarket Cap
LossP/E TTM

Avalo Therapeutics Inc

17.770
-0.380-2.09%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

AVTX Financials

See Avalo Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Avalo Therapeutics Inc Earnings Date

Latest Release
May 13, 2026
EPS / Forecast
-0.98/-1.03
Revenue / Forecast
--/0.00
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
59.00K
-86.62%
EPS(YoY)
-5.84
26.44%
Analyst Rating
STRONG BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
21.93%-0.98
78.10%-0.75
-322.12%-2.19
-145.54%-1.92
99.11%-1.25
66.03%-3.44
103.67%0.98
102.99%4.21
30.75%-141.14
95.95%-10.12
---26.83
---140.61
---203.81
---249.99
---812.69
----
----
----
----
----
Revenue
----
-69.27%59.00K
-100.00%0.00
----
----
-66.37%192.00K
5.51%249.00K
-100.00%0.00
-100.00%0.00
-36.27%571.00K
-98.42%236.00K
-37.75%643.00K
-59.51%475.00K
309.13%896.00K
1007.33%14.95M
-69.21%1.03M
147.99%1.17M
-85.36%219.00K
21.53%1.35M
150.79%3.35M
Net Profit
-49.29%-19.63M
60.98%-13.72M
-660.69%-30.63M
-576.92%-20.77M
89.16%-13.15M
-330.48%-35.16M
204.48%5.46M
153.14%4.35M
-1118.38%-121.29M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
48.89%-9.81M
118.35%3.19M
24.07%-12.99M
28.13%-22.05M
-22.72%-19.20M
-29.25%-17.39M
-28.79%-17.11M
Net Margin
----
-26.34%-23254.24%
----
----
----
-1186.69%-18405.73%
517.64%9251.81%
----
----
-30.63%-1430.47%
---2215.25%
---1274.18%
---2095.79%
---1095.09%
---185.64%
----
----
----
----
----
Gross Margin
----
82.86%100.00%
----
----
----
-60.57%54.69%
8397.48%386.75%
----
----
350.29%138.70%
---4.66%
---10.11%
---16.00%
--30.80%
--83.38%
----
----
----
----
----
Debt to assets ratio
--2.33%
--2.00%
--1.86%
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--58.24%
--54.55%
--58.19%
--52.17%
----
----
----
----
----
Income Statement
Revenue
----
-69.27%59.00K
-100.00%0.00
----
----
-66.37%192.00K
5.51%249.00K
-100.00%0.00
-100.00%0.00
-36.27%571.00K
-98.42%236.00K
-37.75%643.00K
-59.51%475.00K
309.13%896.00K
1007.33%14.95M
-69.21%1.03M
147.99%1.17M
-85.36%219.00K
21.53%1.35M
150.79%3.35M
Operating profit
-42.48%-20.90M
-48.31%-19.74M
-49.27%-19.20M
-103.93%-19.32M
-180.53%-14.67M
-254.87%-13.31M
-242.96%-12.86M
-32.48%-9.47M
40.53%-5.23M
57.64%-3.75M
-191.58%-3.75M
39.55%-7.15M
57.84%-8.79M
50.70%-8.86M
124.87%4.09M
30.95%-11.83M
31.81%-20.85M
-9.94%-17.96M
-24.00%-16.46M
-44.98%-17.13M
Net Profit
-49.29%-19.63M
60.98%-13.72M
-660.69%-30.63M
-576.92%-20.77M
89.16%-13.15M
-330.48%-35.16M
204.48%5.46M
153.14%4.35M
-1118.38%-121.29M
16.75%-8.17M
-263.78%-5.23M
36.91%-8.19M
54.85%-9.96M
48.89%-9.81M
118.35%3.19M
24.07%-12.99M
28.13%-22.05M
-22.72%-19.20M
-29.25%-17.39M
-28.79%-17.11M
Balance Sheet
Current assets
-30.03%88.83M
-24.19%105.29M
32.15%113.85M
20.12%115.19M
14.14%126.94M
1554.44%138.89M
580.53%86.15M
1175.36%95.89M
477.64%111.21M
-48.86%8.39M
-34.92%12.66M
-49.94%7.52M
-55.90%19.25M
-73.46%16.42M
-74.74%19.45M
-68.29%15.02M
-5.29%43.66M
137.82%61.84M
87.67%77.01M
-5.73%47.36M
Total current liabilities
106.57%11.60M
85.92%12.94M
-86.86%7.97M
-90.39%9.26M
-97.40%5.62M
50.71%6.96M
910.39%60.67M
329.31%96.40M
827.94%215.70M
-79.12%4.62M
-66.91%6.00M
45.85%22.45M
29.91%23.25M
11.19%22.11M
-4.67%18.15M
-28.97%15.39M
-32.12%17.89M
30.63%19.89M
14.88%19.04M
48.50%21.67M
Total assets
-27.89%99.89M
-22.74%116.46M
27.06%125.10M
16.87%126.58M
11.96%138.52M
618.01%150.73M
236.37%98.45M
346.90%108.31M
241.46%123.73M
-37.08%20.99M
-19.91%29.27M
-24.79%24.23M
-41.46%36.23M
-58.40%33.37M
-61.67%36.55M
-49.72%32.22M
-2.28%61.90M
83.32%80.21M
61.11%95.36M
-7.40%64.08M
Total liabilities
98.42%31.57M
88.75%33.41M
-55.69%33.55M
-80.07%22.01M
-92.92%15.91M
29.30%17.70M
419.53%75.72M
253.99%110.46M
428.95%224.81M
-69.09%13.69M
-62.22%14.57M
-18.26%31.20M
-23.50%42.50M
-22.49%44.28M
-29.92%38.58M
-10.17%38.17M
84.02%55.56M
197.66%57.13M
166.96%55.05M
128.15%42.50M
Total equity
-44.28%68.32M
-37.57%83.05M
302.69%91.55M
4961.65%104.57M
221.30%122.61M
1721.36%133.03M
54.71%22.73M
69.13%-2.15M
-1512.97%-101.08M
166.92%7.30M
824.61%14.70M
-17.11%-6.97M
-198.80%-6.27M
-147.29%-10.91M
-105.03%-2.03M
-127.57%-5.95M
-80.87%6.34M
-6.02%23.08M
4.52%40.31M
-57.32%21.59M
Cash Flow Statement
Net operating income
-87.07%-17.69M
5.30%-14.25M
-41.97%-16.36M
30.05%-11.39M
-52.48%-9.46M
-443.89%-15.04M
-68.62%-11.53M
-47.68%-16.28M
38.30%-6.20M
29.80%-2.77M
-219.39%-6.84M
11.58%-11.03M
37.44%-10.05M
76.96%-3.94M
135.15%5.73M
35.01%-12.47M
12.28%-16.07M
-18.94%-17.10M
-37.24%-16.29M
-124.30%-19.19M
Net investment
--25.50M
--2.40M
---13.26M
---70.86M
-100.00%0.00
--0.00
--0.00
--0.00
367.67%356.00K
--0.00
100.00%0.00
100.00%0.00
---133.00K
100.00%0.00
51.85%-39.00K
---56.00K
100.00%0.00
97.19%-11.00K
-29.27%-81.00K
-100.00%0.00
Net financing
--1.40M
-98.99%687.00K
--14.37M
0.64%-469.00K
-100.00%0.00
6770800.00%67.71M
-100.00%0.00
-178.93%-472.00K
690.02%108.61M
-98.78%1.00K
--10.70M
104.05%598.00K
--13.75M
7.89%82.00K
-100.00%0.00
-169.66%-14.78M
-100.00%0.00
-62.19%76.00K
--47.64M
-40.21%21.22M

FAQs

What is the total revenue of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its total revenue reached 59.00K, with a year-on-year change of 441.00K.

What are the current assets of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its current assets were 105.29M, with a year-on-year change of -24.19.

What are the total assets of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its total assets of Avalo Therapeutics Inc were 116.46M, with a year-on-year change of -22.74.

What are the total liabilities of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its total liabilities of Avalo Therapeutics Inc were 33.41M, with a year-on-year change of 88.75.

What is the total equity of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its total equity of Avalo Therapeutics Inc was 83.05M, with a year-on-year change of -37.57.

What is the net operating income of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its net operating income of Avalo Therapeutics Inc was -72.92M, with a year-on-year change of -78.43.

What is the net investment of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its net investment of Avalo Therapeutics Inc was -81.72M, with a year-on-year change of -23055.06.

What is the net financing of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its net financing of Avalo Therapeutics Inc was 14.59M, with a year-on-year change of -91.70.

What is the Earnings Per Share (EPS) of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.84, with a year-on-year change of 26.44.

What is the net income of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its net income was -78.26M, with a year-on-year change of -122.78.

What is the net margin of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its net profit margin was -132642.37, with a year-on-year change of -1565.16.

What is the gross margin of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its gross margin was 100.00, with a year-on-year change of -45.35.

What is the debt-to-asset ratio of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its debt-to-asset ratio was 2.00, with a year-on-year change of 29.43.

What is the Return on Equity (ROE) of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -72.43, with a year-on-year change of -44.68.

What is the Return on Assets (ROA) of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -58.58, with a year-on-year change of -43.18.

What is the operating profit of Avalo Therapeutics Inc?

According to Avalo Therapeutics Inc's FY2025 earnings report, its operating profit was -72.92M, with a year-on-year change of -78.43.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy